#48FUZKK atlas leaders 1–100
Hikma Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesSterile and injectable products
Manufacturing profile
Finished dosage forms and small molecules
Sterile and injectable products
Biopharma hub: New Jersey / New York / Pennsylvania
Selection basis
The company is placed in positions 1–100 as a major participant in the U.S. pharmaceutical, biopharmaceutical, generics or manufacturing/CDMO ecosystem.
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Representative manufacturing and QC chain
- 1Raw-material receipt and identification
- 2Dispensing, blending and granulation
- 3Tableting, encapsulation or solution preparation
- 4Packaging and labelling
- 5HPLC, GC, KF, ICP/AAS, dissolution and stability QC
- 6WFI, clean steam and cleanroom HVAC
- 7Solution preparation and bioburden control
- 8Sterile filtration
- 9Isolator/RABS filling or lyophilisation
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerContent Uniformity Quality CheckerDissolution Apparatus 1 & 2 Quality CheckerStability Condition Monitoring Quality CheckerSterility Test Membrane Filtration Quality CheckerBacterial Endotoxins LAL Quality CheckerParticle Count Injection USP <788> Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Methodology